�鶹ѧ����Ʒ��

A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.

Hormone replacement therapy helps women counteract the side effects of menopause. But could it also increase the odds of getting cancer? Cindy Matsen, MD, talks through the risks and benefits.

The Princess of Wales shocked the world when she announced she was undergoing “preventative chemotherapy” for cancer. We asked oncologist Heloisa Soares to help us understand this type of treatment.

Inspired by their father's battle with non-Hodgkin lymphoma, Adalyn Wood and her sisters have generated over $10,000 for cancer research with their Cookies for the Cure stand.

Demand for cancer genetic testing is on the rise, but there’s a national shortage of genetic counselors to guide patients through the process. Researchers say chatbots could be the answer.

Study shows new method forecasts the severity of a patient’s diagnosis and its likelihood of recurrence. This latest information should improve treatment and offers hope by potentially saving countless lives.

Landmark survey illustrates the care barriers that rural and frontier communities face throughout the Mountain West. This groundbreaking work helps Huntsman Cancer Institute address these disparities more effectively.

Heloisa Soares, MD, PhD, and Skyler Johnson, MD, were selected as members of The Society of Huntsman Translational Scholars for their contributions to advancing cancer research and patient care.

Early menopause significantly raises breast cancer risk, highlighting the need for proactive health screenings, according to research from Huntsman Cancer Institute and the Spencer Fox Eccles School of Medicine.

Huntsman Cancer Institute and the Price College of Engineering have selected six teams to receive collaborative grants for a new program that aims to find solutions for cancer problems.

Women with endometriosis are four times more likely to develop ovarian cancer, and those with more severe cases are at an even greater risk.

The interdisciplinary team of lung cancer researcher Michelle Mendoza and biomedical engineer Jeffrey Weiss have received a multimillion dollar grant to study the origin of malignant tumors in the lungs.

Researchers have designed new digital tools that have quadrupled screening rates for patients at high risk for lung cancer.

Confused about clinical trials? Dr. Heloisa Soares clears up some common misconceptions about what it means to participate.

The event provided an opportunity for leaders and staff to listen and learn about the impactful work being done throughout the Area We Serve, while encouraging networking opportunities.